The cancer treatment landscape is rapidly changing with new discoveries and expert guidance emerging. As research, testing and treatment strategies continue to evolve, clinicians must keep abreast of the latest data on molecular mechanisms, emerging therapies, current standards of care, expert guideline updates, and new strategies for treatment. Whether you are looking for education on the value and interpretation of real-world evidence for clinical decision making, translation of efficacy and safety of therapeutic agents to decisions for your patients, or resources to share with patients and families navigating their cancer journey, you’ll find educational activities and resources here to help improve your knowledge and help your patients better take part in their care.
Our activities offer many credit types, including CME, AAFP Prescribed Credit, CNE, CPE, ABIM MOC, and ABP MOC. Each activity has been designed to meet the requirements for CME for MIPS. See each activity’s information page for the exact credit type and amount of credit offered.
In the fourth activity of this CME Outfitters podcast series on gynecologic cancers, expert faculty will present and discuss the very latest research on biomarker testing, specifically for HRD positivity, for first-line treatment of OC.
In the third activity of this CME Outfitters podcast series on gynecologic cancers, expert faculty will present and discuss the very latest research on treatment of endometrial cancer, including strategies that utilize molecular testing and ICI therapies.
In this CME Outfitters recorded symposium expert faculty will evaluate the latest biomarker testing strategies in prostate, bladder, and lung cancer, discussing how to integrate all members of the interdisciplinary care team in community oncology settings, identifying root causes of health inequity in cancer care and how to incorporate strategies to address unconscious bias and provide the latest biomarker testing services in cancer care management.
In the second activity of this CME Outfitters podcast series on gynecologic cancers, Drs. Richard Penson and Matthew Powell will present and discuss the very latest research on emerging treatment options for EC.
In the first activity of this CME Outfitters podcast series on gynecologic cancers, expert faculty will present and discuss the very latest research on maintenance treatment of EC and how to assess its value for newly diagnosed patients and those with recurrent EC.
Data from recent clinical trials for first-line combination options using immunotherapies for ovarian cancer (OC) can be challenging for clinicians with no experience selecting patients for combinatorial treatment approaches or using combination therapies for their patients. During this podcast, Drs. Richard Penson and Ramez Eskander will educate clinicians on the use of immune checkpoint inhibitors for the treatment of OC and the use of biomarker analyses to optimize patient selection.
Recent data has led to a debate of the most effective maintenance strategy for advanced OC. Emerging data utilizing novel approaches to maintenance both further complicates the debate and sheds new light on novel effective strategies for maintenance therapy for advanced OC, leaving clinicians struggling to adopt appropriate strategies. In order to ensure that clinical decisions align with the latest emerging data regarding maintenance therapy in OC, Drs. Richard Penson and Kathleen Moore will educate clinicians on the role of biomarkers in OC, incorporation of genetic testing, and interpretation of results as part of clinical practice.
Multiple clinical practice guidelines for the treatment of endometrial cancer (EC) recommend consideration of molecular testing, particularly for high-grade tumors. Yet despite its prognostic value, molecular classification is not always a part of standard risk assessment in EC. Clinical uptake has been highly variable, particularly in limited-resource areas, even though recent data shows molecular classification has value in therapeutic decision-making and is prognostic for treatment response in EC. Lack of clinical uptake has resulted in overtreatment of some EC patients and undertreatment of others.
During this informational podcast, leading national endometrial cancer experts, Drs. Richard Penson and Matthew Powell, will discuss molecular classification of EC and the clinical data supporting it’s value in EC care.
In this 45-minute interactive CME Outfitters Snack, a diverse panel of expert faculty will discuss the evolving treatment landscape of metastatic breast cancer and how to integrate the latest clinical evidence, real world evidence, and treatment guideline recommendations to foster patient health literacy, shared-decision making, and individualized outcomes.
In this CME Outfitters podcast, expert faculty will review recent data and discuss the impact of biases, disparities, and health inequities that reduce the quality of oncology care for racial and ethnic underserved patients with prostate cancer. This program will set the stage for intervention, empowering attendees to recognize and consider factors to improve prostate cancer treatment.
Join a faculty expert as they guide learners through a patient case scenario reflecting the impact of biases, disparities, and health inequities that reduce the quality of care for patients with prostate cancer. This program will provide actionable strategies, empowering attendees to recognize factors and implement changes in practice to improve prostate cancer treatment.
In this CME Outfitters BriefCase, faculty experts will guide learners through a patient case scenario reflecting the impact of biases, disparities, and health inequities that reduce the quality of oncology care for racial and ethnic underserved patients with multiple myeloma.
Join Drs. Ana I. Velázquez Mañana and Gilberto de Lima Lopes, Jr. as they review recent data and discuss the impact of biases, disparities, and health inequities that reduce the quality of oncology care for underserved racial and ethnic underserved patients with lung cancer.
In this CME Outfitters podcast, expert faculty will review recent data and discuss the sweeping impact of biases, disparities, and health inequities that reduce the quality of oncology care for racial and ethnic underserved patients with multiple myeloma.
In this CMEO BriefCase, a faculty expert will guide learners through a patient case scenario reflecting the impact of biases, disparities, and health inequities that reduce the quality of oncology care for racial and ethnic underserved patients with lung cancer.
Join a faculty expert as they guide learners through a patient case scenario reflective of the impact of biases, disparities, and health inequities that reduce the quality of oncology care for racial and ethnic underserved patients with melanoma.
In this CME Outfitters webcast, expert faculty discuss the impact of unconscious and systemic biases, SDoH, and regional, racial, and ethnic disparities and provide tools and resources to improve oncology care for all patients.
